SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-19-012045
Filing Date
2019-10-01
Accepted
2019-10-01 11:55:47
Documents
1
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156994532484636.html 4  
1 FORM 4 wf-form4_156994532484636.xml 4 5656
  Complete submission text file 0001628280-19-012045.txt   7172
Mailing Address C/O EVOFEM BIOSCIENCES, INC. 12400 HIGH BLUFF DRIVE, SUITE 600 SAN DIEGO CA 92130
Business Address
Lynch Thomas G (Reporting) CIK: 0001360000 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36754 | Film No.: 191128148

Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Issuer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations